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Abstract
The nonstructural proteins 1 (NS1) from influenza A and B viruses are known as the main viral factors antagonising
the cellular interferon (IFN) response, inter alia by inhibiting the retinoic acid-inducible gene I (RIG-I) signalling. The
cytosolic pattern-recognition receptor RIG-I senses double-stranded RNA and 5’-triphosphate RNA produced during
RNA virus infections. Binding to these ligands activates RIG-I and in turn the IFN signalling. We now report that the
influenza C virus NS1 protein also inhibits the RIG-I-mediated IFN signalling. Employing luciferase-reporter assays,
we show that expression of NS1-C proteins of virus strains C/JJ/50 and C/JHB/1/66 considerably reduced the IFN-b
promoter activity. Mapping of the regions from NS1-C of both strains involved in IFN-b promoter inhibition
showed that the N-terminal 49 amino acids are dispensable, while the C-terminus is required for proper
modulation of the IFN response. When a mutant RIG-I, which is constitutively active without ligand binding, was
employed, NS1-C still inhibited the downstream signalling, indicating that IFN inhibitory properties of NS1-C are
not necessarily linked to an RNA binding mechanism.
Background
Innate immune response is the first unspecific defence
against viral infections, in which the induction of type I
IFNs is essential for controlling influenza virus replica-
tion and spread. Recently, RIG-I has been identified as
the major cytosolic pattern-recognition receptor sensing
RNA in influenza virus-infected cells, thereby initiating
the IFN signalling [1,2]. RIG-I, which belongs to the
DExD/H box family of RNA helicases, consists of two
N-terminal caspase activation and recruitment domains
(CARDs), an internal ATP-dependent RNA helicase
domain, and a C-terminal repressor domain that holds
the protein in an inactive state [3,4]. Binding of the
repressor domain to dsRNA or 5’-triphosphate RNA, at
least the latter of which is present in detectable amounts
during influenza virus infections [5], induces a confor-
mational change that leads to exposition of the CARDs.
Tripartite motif protein 25 (TRIM25) interacts with the
first CARD of RIG-I and ubiquitinates the second
CARD [6]. Ubiquitinated RIG-I proteins multimerise
and form a complex with mitochondrial antiviral signal-
ling adaptor (MAVS), also termed IPS-1/Cardif/Visa.
The subsequent signal cascade leads to activation of
transcription factors IRF3, IRF7, AFT-2/c-Jun, and
NFB, which translocate to the nucleus to form the
IFN-b enhanceosome. The IFN-b expression results in
transcription of more than 100 IFN-induced genes,
many of which are known to exhibit anti-influenza virus
activity (reviewed in [7]).
For influenza A and B viruses, NS1 has been identified
as the main antiviral protein antagonising the cellular
IFN signalling. The influenza A virus NS1 has been
reported to inhibit RIG-I-mediated IFN synthesis [8-10].
This IFN inhibitory property has been discussed to be
due to its RNA-binding activity [11,12], which is impor-
tant for optimal inhibition of type I IFN induction
[13,14]. Besides sequestering viral RNA from being
detected by RIG-I, NS1-A can also interact with the
RIG-I complex independently of an RNA bridge. Expres-
sion of NS1-A inhibited IFN induction by a constitu-
tively activated RIG-I protein lacking the helicase and
repressor domains [9]. Recently, human TRIM25 protein
was identified as an NS1-binding protein too, and NS1-
TRIM25 complex formation led to inhibition of RIG-I
ubiquitination and consequently its downstream signal-
ling [15]. Earlier studies on the modulation of the IFN-b
production by NS1-A indicated that NS1-A inhibits acti-
vation of transcription factors NFB, IRF3, and AFT-2/
c-Jun [16-18], obviously as a result of its interference
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mediated IFN-b expression, NS1-A has been found to
inhibit the activity of the IFN-induced antiviral proteins
protein kinase R (PKR) and 2’-5’-oligoadenylate synthe-
tase (OAS). Moreover, NS1-A has been shown to bind
to components involved in cellular mRNA processing,
export, and translation, thereby inhibiting cellular pro-
tein synthesis (reviewed in [7]). Like NS1-A, the influ-
enza B virus NS1 protein is essential for the regulation
of RIG-I-mediated IFN-b production (reviewed in [7]).
In contrast, no reports are available how influenza C
virus modulates the immune response.
Influenza C virus harbours seven single-stranded RNA
segments of negative polarity, of which the smallest seg-
ment, NS, codes for NS1 and, from a spliced mRNA
transcript, for nuclear export protein/nonstructural pro-
tein 2 (NEP/NS2). The NS1 proteins of influenza C
virus strains are commonly composed of 246 amino
acids [19]. We have recently investigated that NS1-C
from strain C/JJ/50 is in contrast made of only 239
amino acids [20]. Muraki et al. [21] have reported that
NS1-C is involved in splicing of viral mRNAs and that it
is localised in the nucleus in an early stage of infection,
while in later stages of infection it predominantly resides
in the cytoplasm. This cytoplasmic localisation may
reflect RIG-I antagonising properties of NS1-C.
To elucidate whether NS1 from influenza C virus also
counteracts the cellular IFN response, we examined the
effect of NS1 expression on the IFN-b promoter activity
in HEK-293TN cells using a luciferase-reporter assay.
Results and Discussion
First, plasmids expressing full-length and truncated NS1
from influenza C virus strains C/JJ/50 and C/JHB/1/66
were generated (Figure 1). pCI-NS1(SAM)-JJ and -JHB
code for the entire NS1 proteins from both strains. The
NS1 cDNAs were PCR-amplified from templates pPMV-
NS and pPMV-NS-C/JHB/1/66 [20]. In order to prevent
formation of NEP/NS2, the splice-acceptor sites of NS
were mutated via internal primers: For strain C/JJ/50,
nucleotide 504, for strain C/JHB/1/66, nucleotide 525
was changed from A to C, which does not affect the
amino acid sequences of NS1. The PCR fragments were
internally ligated with BsmBI s i t e s .T h ee n t i r eN S 1f r a g -
ments were cloned into vector pCI (Promega) via NheI
and XbaI restriction sites. To construct plasmids for
expression of C-terminally truncated NS1 proteins from
both virus strains (pCI-NS1-95-JJ and pCI-NS1-102-JHB,
pCI-NS1-143-JJ and pCI-NS1-150-JHB, and pCI-NS1-
208-JJ and pCI-NS1-215-JHB), the different-sized NS1
fragments were PCR-amplified from the respective pCI-
NS1(SAM) templates with reverse primers introducing
two stop codons and were cloned into XhoI and XbaI
restriction sites of vector pCI. For generation of plasmids
encoding N-terminally truncated NS1 proteins (pCI-
NS1-50-239-JJ and pCI-NS1-50-246-JHB), NS1 frag-
ments were PCR-amplified with the respective pCI-NS1
(SAM) templates and a forward primer adding a start
codon upstream of amino acid 50. The fragments were
inserted into pCI with XhoI and XbaI restriction sites.
In a first set of experiments, 90% confluent HEK-
293TN cells in 24-well plates (kindly provided by
Dr. Albert Duschl, University of Salzburg), maintained
in Dulbecco’s modified Eagle’s medium with 10% fetal
bovine serum and 2 mM L-glutamine, were cotrans-
fected with 500 ng of one of the plasmids encoding full-
length NS1 (pCI-NS1[SAM]-JJo rp C I - N S 1 [ S A M ] - J H B ) ,
or with empty pCI vector as control, together with
250 ng of a reporter plasmid for IFN-b promoter activity
(pGL4.10-IFN-b-prom). pGL4.10-IFN-b-prom encodes
luciferase under the control of the murine IFN-b pro-
moter. Nucleotides -125 to +19 of the IFN-b promoter,
Figure 1 Overview of NS derivatives constructed from influenza C/JJ/50 and C/JHB/1/66 viruses. Sequences are shown in positive sense.
NS1(SAM)-JJ and NS1(SAM)-JHB have wild type-like sequence lengths but are splice acceptor site-mutated (SAM) to prevent NEP/NS2 expression.
Start and stop codons - whether native or introduced by cloning - are depicted. Black bars: noncoding ends. All primer sequences are available
upon request.
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immediately upstream of the firefly luciferase gene
(luc2) of the promoterless vector pGL4.10 (Promega) via
NheI and NcoI restriction sites. In addition, 50 ng of a
plasmid expressing b-galactosidase (p4TO/lacZ, kindly
provided by Dr. Annemarie Frischauf, University of Salz-
burg) as internal transfection reference and 50 ng of a
RIG-I expression plasmid (pCI-RIG-I) were included.
pCI-RIG-I encodes the full-length human RIG-I (925
amino acids). Plasmid pCR-XL-TOPO-BC136610 (pur-
chased from Open Biosystems) served as template to
amplify the 2778-nucleotide ORF of RIG-I, which was
inserted into vector pCI via XhoI and NotI restriction
sites. Transfections were performed with 2 μl of Lipofec-
tamine 2000 (Invitrogen) in Opti-MEM medium with
Glutamax (Invitrogen). Six hours post transfection, the
transfection mixes were changed for 1 ml Opti-MEM
with Glutamax. 24 hours post transfection, cells were
stimulated with 1 μg poly(I:C) (purchased from Sigma-
Aldrich) or 800 ng vRNA (isolated from egg-grown
influenza C virus using QiaAmp viral RNA mini kit
according to Qiagen’s instructions, and subsequently
digested with DNAseI), again by transfection with 2 μl
Lipofectamine 2000. Eight hours post induction, cells
were lysed in 80 μl cell culture lysis reagent (Promega),
and supernatants were cleared by centrifugation. To
determine luciferase activity of cell supernatants, 20 μl
of each sample were mixed with Luciferase Assay
Reagent (Promega) and measured by a GloMax™ 96
Microplate Luminometer (from Promega, kindly pro-
vided by Dr. Arnulf Hartl, Paracelsus Medical Private
University, Salzburg) according to the manufacturer’s
recommendations. As internal transfection reference,
b-galactosidase activity (from plasmid p4TO/lacZ) of
samples was measured as well: 10 μl of cell supernatants
were mixed with 125 μl of Z-buffer (100 mM sodium
phosphate, pH 7.4, 10 mM KCl, 1 mM MgSO4,5 0m M
2-mercaptoethanol) and 25 μlo fO N P Gs o l u t i o n
(4 mg/ml Ortho-nitrophenyl-b-D-galactopyranoside
from Sigma in 100 mM NaPO4, pH 7.4). The OD at 415
nm of the samples was determined with Spectra Fluor
spectrafluorimeter (Tecan) for three times with one
minute delay between every read. The change in OD
per minute (ΔOD/min) was calculated. Finally, the value
of luciferase activity was divided through the ΔOD/min
of b-galactosidase activity to gain the normalised lucifer-
ase activity. All transfection assays were performed three
times in duplicates.
As HEK-293TN cells do not express a pattern-
recognition receptor for influenza virus detection, with-
out ectopic RIG-I expression the IFN-b promoter was
hardly switched on (Figure 2). In contrast, in cells trans-
fected with RIG-I and stimulated with poly(I:C) or
vRNA, the IFN-b promoter was highly activated. With
addition of NS1 from either strain C/JJ/50 or C/JHB/1/
66, this IFN-b promoter activation was clearly dimin-
ished. When cells had been stimulated with the syn-
thetic dsRNA poly(I:C), cotransfected NS1 led to a
Figure 2 NS1-C inhibits IFN-b promoter activity induced by RIG-I. HEK-293TN cells were transiently transfected with IFN-b luciferase reporter
plasmid, RIG-I and b-galactosidase expression plasmids, and vectors encoding NS1 from C/JJ/50 or C/JHB/1/66, or empty pCI vector. 24 h post
transfection, cells were stimulated with poly(I:C) or vRNA, and eight hours post induction, luciferase activity of cell lysates was measured and
normalised to b-galactosidase activity. Data shown are representative for three experiments with transfections performed in duplicates. Error bars
indicate standard deviations. The zero control without ectopic RIG-I expression is depicted at the left.
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had been induced with vRNA from influenza C virus,
reporter activity even equalled the zero control (without
ectopic RIG-I) in the presence of NS1.
Next, the regions of NS1 involved in IFN-b promoter
inhibition were determined. HEK-293TN cells were
transfected with the IFN-b promoter reporter plasmid,
RIG-I plasmid, and b-galactosidase plasmid along with
either full-length or truncated NS1 expression plasmids
(see Figure 1). In a first round of experiments, RIG-I
was induced with poly(I:C). As shown in Figure 3, all
C-terminally truncated NS1 proteins did not support
IFN-b promoter inhibition. On the contrary, these NS1
derivatives even seemed to stimulate IFN-b promoter
activity. The greater the C-terminal deletion, the more
strongly the reporter was activated. In contrast, the N-
terminally deleted NS1 variants (NS1-50-239-JJ and
NS1-50-246-JHB) led to suppression of the IFN-b pro-
moter. But the effect of these shortened NS1 proteins
was not as strong as the influence of the full-length iso-
forms. When RIG-I was induced with vRNA, the IFN-b
inhibitory properties of the N-terminally deleted NS1
proteins were strengthened.
To find out whether NS1-C also prevents RIG-I-
induced IFN signalling independent of an RNA-
binding mechanism, as reported for influenza A virus
NS1 [9], reporter-transfection experiments were car-
ried out with a mutant RIG-I protein. RIG-I-N lacks
the helicase and repressor domains and is consequently
active without RNA stimulation [2]. Vector pCI-RIG-I-
N was generated, which codes for the N-terminal 284
amino acids of human RIG-I protein. From template
plasmid pCR-XL-TOPO-BC136610, an 858 nucleotides
long fragment (including two stop codons introduced
by reverse primer) was cloned into vector pCI via XhoI
and NotI restriction sites. Cell transfections were per-
formed as outlined before, with the difference that
no RNA was necessary for induction. As shown in
Figure 4, transfection of the mutant RIG-I resulted in
even elevated IFN-b promoter activity (compare to
Figure 2). In the presence of NS1, this IFN-b promoter
activation was decreased, whereat NS1 from strain C/
JHB/1/66 exhibited stronger inhibitory effects. The N-
terminally truncated NS1 proteins from both strains
(NS1-50-239-JJ and NS1-50-246-JHB) antagonised the
IFN-b promoter activity to an even higher extent. And
- most strikingly - even NS1 proteins missing the C-
terminal 31 amino acids (NS1-208-JJ and NS1-215-
JHB) showed IFN inhibitory properties. All shorter
NS1 proteins did not reduce reporter activity, but on
the contrary stimulated reporter activity (data not
shown). This effect had also been observed in the pre-
s e n c eo ff u l l - l e n g t hR I G - I( s e eF i g u r e3 ) .T h e s ed a t a
suggest that NS1-C interacts with components of the
IFN signalling independent of an RNA bridge.
Whether NS1-C binds to and consequently shields
vRNA from being detected by a pattern-recognition
receptor remains to be studied in future experiments.
Figure 3 Impact of truncated NS1 proteins on IFN-b promoter activity. HEK-293TN cells were transiently transfected with IFN-b luciferase
reporter plasmid, RIG-I and b-galactosidase expression plasmids, and vectors encoding full-length or truncated NS1 from C/JJ/50 or C/JHB/1/66,
or empty pCI vector. 24 h post transfection, RIG-I was induced with poly(I:C) or vRNA, and eight hours post induction, luciferase activities of cell
lysates were measured and normalised to b-galactosidase activities. Only full-length and N-terminally-truncated NS1 proteins inhibited reporter
activity. Error bars indicate standard deviations.
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In conclusion, the results of this study demonstrate that
influenza C virus NS1 protein has IFN antagonistic prop-
erties like the respective proteins from influenza A and B
viruses. Mapping of the NS1 regions involved in inhibi-
tion of the IFN-b promoter showed that proteins devoid
of the N-terminal 49 amino acids still exhibited IFN
antagonistic properties. NS1 proteins missing parts of the
C-terminus rather stimulated IFN-b promoter activation.
The shorter the NS1 C-terminal portion, the greater the
stimulation was observed. Therefore, both N- and
C-terminal parts of the full-length NS1-C protein are
apparently involved in contacting a component of the
RIG-I-mediated signalling, and the C-terminus seems to
inhibit downstream signalling. The C-terminally trun-
cated NS1-C proteins lose this inhibitory property, but
still seem to contact their counterparts in RIG-I signal-
ling and lead to activation. In contrast, for NS1-A the
first 73 amino acids, which harbour RNA-binding activ-
ity, were reported to be sufficient for inhibition of the
IFN signalling [22]. In case of NS1-B, both the
N-terminal 93 amino acids as well as the remaining C-ter-
minus could independently regulate the IFN response [23].
Expression of NS1-C also inhibited the signalling
mediated by RIG-I-N, suggesting that NS1-C acts as
IFN antagonist independent of an RNA binding
mechanism. In the presence of RIG-I-N, the N-
terminally deleted NS1-C proteins as well as NS1-C pro-
teins lacking the C-terminal 31 amino acids suppressed
the IFN-b promoter-dependent expression. How exactly
the NS1-C protein interacts with components of the
RIG-I-directed IFN signalling may only be hypothesised
at the moment. NS1-C may get in contact with the
RIG-I-TRIM25 complex, inhibiting ubiquitination of the
RIG-I CARD, as observed for NS1-A. As the ultimate
C-terminal amino acids are not required for inhibition
of IFN signalling initiated by RIG-I-N, but are necessary
for inhibition of RIG-I-mediated signalling, this C-termi-
nus of NS1-C may specifically interact with a C-terminal
part of RIG-I or RNA bound to RIG-I. As NS1-C
enhances viral mRNA splicing [21], it has obviously
RNA-binding activity.
On basis of this work and our recently established sys-
tem for the rescue of recombinant influenza C viruses
[20], NS1-mutated attenuated recombinant influenza C
viruses may be created to investigate the roles of NS1 in
more detail. Moreover, the generated NS1-truncated
plasmids may be employed for determination of the
regions of NS1 important for its splicing activity.
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Figure 4 NS1-C antagonises IFN response in the absence of an RNA stimulus. HEK-293TN cells were transfected with IFN-b luciferase
reporter plasmid, plasmids encoding mutant RIG-I (RIG-I-N) and b-galactosidase, and vectors encoding full-length or truncated NS1 from C/JJ/50
or C/JHB/1/66, or empty pCI vector. Relative luciferase activities of cell lysates 32 hours post transfection were determined. Error bars indicate
standard deviations.
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